Drugs / Folrex
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01016119 | Oct 2009 → Mar 2010 | stroke disorder | Catalysis SL | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Folrex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01016119 ↗ |